Education
- 2003: PhD in Endocrinology, University of Milan
- 1997: Post-Graduate degree in Endocrinology, University of Milan
- 1991: MD degree, University of Milan
Academic Appointments
- 2015 – 2022: Associate Professor of Endocrinology, Department of Biomedical Sciences, 麻豆传媒AV在线看 University
- 2005 – 2015: Assistant Professor, University of Milan, Italy
Other
- Director of Postgraduate Residency Program for Endocrinology at 麻豆传媒AV在线看 University
- Member of The Quality Presidium at 麻豆传媒AV在线看 University
- Director of Endocrinology, Diabetology and Andrology Units at IRCCS 麻豆传媒AV在线看 Research Hospital
- Director of the Endocrinolgy, Diabetology and Andrology Unit and the Laboratory of Cellular and Molecular Endocrinology at IRCCS Istituto Clinico 麻豆传媒AV在线看
- Coordinator (with Prof. Zerbi) of the Neuroendocrine multidisciplinary tumor board certified as Center of Excellence by the European NeuroEndocrine Tumors Society (ENETS)
- 麻豆传媒AV在线看 Research Hospital Health Care Representative at ERN EURACAN (European Reference Network on adult cancer 鈥� solid tumors)
Prof. Andrea Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604) Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors.
Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors. Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors.
Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.
- Mirani M, Favacchio G, Carrone F, Betella N, Biamonte E, Morenghi E, Mazziotti G, Lania AG. Diabetes Care. 2020 Dec;43(12):3042-3049. doi: 10.2337/dc20-1340. Epub 2020 Oct 6. PMID: 33023989.
- Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. . Eur J Endocrinol. 2020 Oct;183(4):381-387. doi: 10.1530/EJE-20-0335. PMID: 32698147.
- Vitali E, Boemi I, Tarantola G, Piccini S, Zerbi A, Veronesi G, Baldelli R, Mazziotti G, Smiroldo V, Lavezzi E, Spada A, Mantovani G, Lania AG. . Cancers (Basel). 2020 Aug 2;12(8):2143. doi: 10.3390/cancers12082143. PMID: 32748870; PMCID: PMC7464161.
- Vitali E, Cambiaghi V, Zerbi A, Carnaghi C, Colombo P, Peverelli E, Spada A, Mantovani G, Lania AG. . Endocr Relat Cancer. 2016 Mar;23(3):181-90. doi: 10.1530/ERC-15-0358. Epub 2016 Jan 5. PMID: 26733502.
- Lania AG, Mantovani G, Ferrero S, Pellegrini C, Bondioni S, Peverelli E, Braidotti P, Locatelli M, Zavanone ML, Ferrante E, Bosari S, Beck-Peccoz P, Spada A. . Cancer Res. 2004 Dec 15;64(24):9193-8. doi: 10.1158/0008-5472.CAN-04-1847. PMID: 15604292.